PubRank

Manjit S Bains

Author PubWeight™ 65.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008 2.93
2 Results of chest wall resection and reconstruction with and without rigid prosthesis. Ann Thorac Surg 2006 2.77
3 American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol 2007 2.41
4 Use of video-assisted thoracic surgery for lobectomy in the elderly results in fewer complications. Ann Thorac Surg 2008 2.33
5 Post-treatment endoscopic biopsy is a poor-predictor of pathologic response in patients undergoing chemoradiation therapy for esophageal cancer. Ann Surg 2009 2.32
6 Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 2004 2.22
7 Video-assisted thoracoscopic surgery (VATS) lobectomy: catastrophic intraoperative complications. J Thorac Cardiovasc Surg 2011 2.11
8 Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 2003 2.04
9 Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. Ann Thorac Surg 2006 2.03
10 The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg 2004 1.97
11 Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. Ann Thorac Surg 2009 1.88
12 Endoscopic retrograde dilation of completely occlusive esophageal strictures. Ann Thorac Surg 2006 1.71
13 The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 2006 1.70
14 Contemporary results of surgical resection of non-small cell lung cancer after induction therapy: a review of 549 consecutive cases. J Thorac Oncol 2011 1.69
15 Predictors of outcomes after surgical treatment of synchronous primary lung cancers. J Thorac Oncol 2010 1.61
16 Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. Chest 2005 1.49
17 Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. J Clin Oncol 2002 1.41
18 Management of major hemorrhage during mediastinoscopy. J Thorac Cardiovasc Surg 2003 1.32
19 Predictive value of initial PET-SUVmax in patients with locally advanced esophageal and gastroesophageal junction adenocarcinoma. J Thorac Oncol 2009 1.25
20 Patterns of recurrence and incidence of second primary tumors after lobectomy by means of video-assisted thoracoscopic surgery (VATS) versus thoracotomy for lung cancer. J Thorac Cardiovasc Surg 2010 1.25
21 Giant benign esophageal schwannoma requiring esophagectomy. Ann Thorac Surg 2006 1.21
22 Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. Ann Thorac Surg 2002 1.21
23 Incidence and risk factors for lung injury after lung cancer resection. Ann Thorac Surg 2007 1.19
24 A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis. Lung Cancer 2002 1.18
25 Esophageal cancer recurrence patterns and implications for surveillance. J Thorac Oncol 2013 1.16
26 Comparison of patterns of relapse in thymic carcinoma and thymoma. J Thorac Cardiovasc Surg 2009 1.15
27 Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 2007 1.10
28 Surgical management of thoracic malignancies invading the heart or great vessels. Ann Thorac Surg 2004 1.07
29 Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy. J Clin Oncol 2004 1.05
30 Resection of primary mediastinal non-seminomatous germ cell tumors: a 28-year experience at memorial sloan-kettering cancer center. J Thorac Oncol 2011 1.04
31 Mortality increases for octogenarians undergoing esophagogastrectomy for esophageal cancer. Ann Thorac Surg 2006 1.01
32 Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol 2006 0.99
33 Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer: Comparison of Robotic, Video-assisted Thoracic Surgery, and Thoracotomy Lobectomy. Ann Surg 2017 0.97
34 Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers. J Thorac Oncol 2013 0.95
35 Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg 2007 0.92
36 Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer: Comparison of Robotic, Video-assisted Thoracic Surgery, and Thoracotomy Lobectomy. Ann Surg 2016 0.91
37 Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction. J Am Coll Surg 2007 0.90
38 Brain natriuretic peptide and risk of atrial fibrillation after thoracic surgery. J Thorac Cardiovasc Surg 2012 0.87
39 Combined thoracoscopic and laparoscopic robotic-assisted minimally invasive esophagectomy using a four-arm platform: experience, technique and cautions during early procedure development. Eur J Cardiothorac Surg 2013 0.85
40 Type I thyroplasty for acute unilateral vocal fold paralysis following intrathoracic surgery. Ann Otol Rhinol Laryngol 2002 0.84
41 Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab. Cancer Chemother Pharmacol 2013 0.83
42 Attaining Proficiency in Robotic-Assisted Minimally Invasive Esophagectomy While Maximizing Safety During Procedure Development. Innovations (Phila) 2016 0.82
43 Prognostic factors after combined modality treatment of squamous cell carcinoma of the esophagus. J Thorac Oncol 2007 0.81
44 Intraoperative near-infrared fluorescence imaging as an adjunct to robotic-assisted minimally invasive esophagectomy. Innovations (Phila) 2014 0.81
45 Endoluminal high-dose-rate brachytherapy for early stage and recurrent esophageal cancer in medically inoperable patients. Brachytherapy 2013 0.80
46 Management dilemmas due to a paratracheal follicular dendritic cell tumor. Ann Thorac Surg 2006 0.80
47 Phrenic nerve injury resulting from percutaneous ablation of lung malignancy. AJR Am J Roentgenol 2008 0.80
48 Surgical treatment of superior sulcus tumors with spinal and brachial plexus involvement. J Neurosurg 2002 0.79
49 Imaging and clinicopathologic features of esophageal gastrointestinal stromal tumors. AJR Am J Roentgenol 2014 0.77
50 Computed tomography-guided access to the cisterna chyli: introduction of a technique for direct lymphangiography to evaluate and treat chylothorax. Cardiovasc Intervent Radiol 2010 0.77
51 Chylothorax and Recurrent Laryngeal Nerve Injury Associated With Robotic Video-Assisted Mediastinal Lymph Node Dissection. Innovations (Phila) 2015 0.75
52 Nael Martini: a leader in thoracic surgical oncology. Ann Thorac Surg 2010 0.75
53 Randomized clinical trials in esophageal cancer. Surg Oncol Clin N Am 2002 0.75
54 One-lung isolation using a double-balloon blocker technique. J Cardiothorac Vasc Anesth 2005 0.75